Avecho Biotechnology Limited (ASX: AVE)
Sector: Health Care
Market cap: A$54M (as of 2 Nov 2026)
Avecho is focused on developing and commercialising innovative Human Health, Animal Health and Personal Care products using its proprietary drug delivery system, TPM.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 27 Feb 2026 | Mark Gregory Kerr & associates | Entry | ?% → 9.5% | Filing ↗ |
| 24 June 2025 | Mark Gregory Kerr & associates | Decrease | 11.520% → 11.000% | Filing ↗ |
| 7 Mar 2025 | Mark Gregory Kerr & associates | Unknown | — | Filing ↗ |
| 16 May 2023 | Mark Gregory Kerr & associates | Decrease | 15.79% → 11.52% | Filing ↗ |
| 22 Oct 2019 | Mark Gregory KERR | Increase | 10.725% → 12.6479% | Filing ↗ |
Cash and runway
Ask about AVE in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has AVE raised money in the last year, and at what discount?
- What was AVE's latest cash position and runway?
Loading AVE…